VANNUCCHI, SIMONETTA
 Distribuzione geografica
Continente #
NA - Nord America 1.809
EU - Europa 907
AS - Asia 160
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 2.880
Nazione #
US - Stati Uniti d'America 1.801
SE - Svezia 226
IE - Irlanda 156
PL - Polonia 134
UA - Ucraina 97
IT - Italia 81
HK - Hong Kong 73
DE - Germania 72
FI - Finlandia 40
GB - Regno Unito 40
CN - Cina 32
SG - Singapore 23
TR - Turchia 20
RU - Federazione Russa 19
FR - Francia 11
CA - Canada 8
JO - Giordania 8
RO - Romania 7
BG - Bulgaria 5
CH - Svizzera 5
AT - Austria 4
LV - Lettonia 3
NL - Olanda 3
BE - Belgio 2
SC - Seychelles 2
VN - Vietnam 2
BR - Brasile 1
CY - Cipro 1
CZ - Repubblica Ceca 1
EU - Europa 1
IN - India 1
NO - Norvegia 1
Totale 2.880
Città #
Fairfield 257
Chandler 223
Jacksonville 175
Dublin 156
Woodbridge 143
Ashburn 136
Warsaw 134
Seattle 107
Cambridge 104
Houston 100
Wilmington 97
Princeton 45
Ann Arbor 43
Hong Kong 40
Boston 33
Boardman 30
Buffalo 30
Medford 17
Izmir 15
Florence 12
Shanghai 12
Singapore 10
Falls Church 9
New York 9
Beijing 8
San Diego 8
Toronto 8
West Jordan 8
Altamura 7
Andover 7
Milan 7
Frankfurt Am Main 6
Lawrence 6
Timisoara 6
Bern 5
Sofia 5
Verona 5
Kent 4
Los Angeles 4
Norwalk 4
Vienna 4
Hillsboro 3
Riga 3
Simpsonville 3
Auburn Hills 2
Brussels 2
Casagiove 2
Dong Ket 2
Frankfurt am Main 2
Laurel 2
Old Bridge 2
Padova 2
Phoenix 2
Rome 2
Salerno 2
San Giorgio A Cremano 2
Siena 2
Albano Laziale 1
Arnsberg 1
Basking Ridge 1
Bremen 1
Catania 1
Chiswick 1
Dearborn 1
Fuzhou 1
Hanover 1
Hounslow 1
Istanbul 1
Jinan 1
London 1
Naaldwijk 1
New Orleans 1
Nicosia 1
Olomouc 1
Oslo 1
Pieve Fosciana 1
Pulsano 1
Redmond 1
Redwood City 1
Reggio Emilia 1
Scandicci 1
St Louis 1
Tappahannock 1
Thiene 1
Totale 2.101
Nome #
Heparin/heparan sulfate anticoagulant glycosaminoglycans in human plasma of healthy donors: preliminary study on a small group of recruits. 209
Transformation by ras oncogene induces nuclear shift of protein kinase C 117
Heparin binding peptides co-purify with glycosaminoglycans from human plasma 115
Interaction between endogenous circulating sulfated glycosaminoglycans and plasma proteins 114
Sulphated polysaccharides and the differentiation of the cellular slime mould Dictyostelium discoideum 103
Surface glycosaminoglycans and calcium distribution in 3T3 cells. 101
Intercellular glycosaminoglycans in human cancer 100
GLYCOSAMINOGLYCANS AND EUKARIOTIC CELL CONTROL. 96
CELL SURFACE GLYCOSAMINOGLYCANS IN NORMAL END LEUKEMIC LEUKOCYTES. 93
Antiproliferative effects of heparin on normal and transformed NIH/3T3 fibroblasts 88
Cell surface glycosaminoglycans in normal and leukemic leukocytes. 87
Isolation of endogenous anticoagulant N-sulfated glycosaminoglycans in human plasma from healthy subjects 85
ELECTROPHORETIC CHARACTERIZATION OF SURFACE HEPARAN SULPHATES IN NORMAL AND VIRUS TRANSFORMED 3T3 CELLS. 85
Effects of 0,2 T static magnetic field on human skin fibroblasts 84
I GLICOSAMINOGLICANI NELL'ADESIONE DEI LEUCOCITI POLIMORFONUCLEATI E DELLE PIASTRINE. 81
Glycosaminoglycan changes involved in polymorphonuclear leukocyte activation in vitro. 81
Cooperative effect of exogenous heparin-like compounds and secreted glucocorticoid-induced inhibitor on plasminogen activator in 3T3 cell cultures. 81
Adhesion-dependent heparin production by platelets. 78
Cell surface glycosaminoglycans in normal and leukemic leukocytes. 78
Transdermal delivery of heparin using pulsed current iontophoresis 72
A method for separation of heparin species from biological samples by ethanol precipitation of compounds solubilized in guanidine hydrochloride. 71
Proteolysis of human plasma reveals the presence of complexes formed by endogenous heparin and peptides that stimulate angiogenesis 70
Binding, internalization and degradation of heparin and heparin fragments by cultured endothelial cells 69
Internalization and metabolism of endogenous heparin by cultured endothelial cells 68
Involvement of chondroitin sulphate in preventing adhesive cellular interactions 67
Cell-type-independent accumulation of phosphatidic acid induced by trifluoperazine in stimulated human platelets, leukocytes and fibroblasts 66
Distribuzione dei glicosaminoglicani nelle frazioni di Cohn-Oncley di plasma umano 56
Angiogenic effects of human circulating endogenous heparin 53
Inhibition of BC3H-1 cell growth by heparin is related to decreased mitogenic signalling 51
Poly-L-lysine/heparin stimulates angiogenesis in chick embryo chorioallantoic membrane 47
Improved method for analysis of glycosaminoglycans in glycosaminoglycan/protein mistures: application in Cohn-Oncley fractions of human plasma 44
Intercellular glycosaminoglycans in normal and neoplastic tissues 43
Involvement of modulation of cell coat glycosaminoglycans in guinea pig peritoneal macrophage activity 40
Pulsed current iontophoresis allows the transdermal transport of heparin 36
Gruppi di auto-aiuto psichiatrico in Toscana: ricostruzione del modello di lavoro attuale attraverso il confronto qualitativo tra motivazioni dei partecipanti e obiettivi istituzionali. 35
Circulating human heparin stimulates angiogenesis in chick embryo chorioallantoic membrane. 31
Point-mutated p2lras couples a muscarinic receptor to calcium channels and polyphosphoinositide hydrolysis 27
Effect of heparin on proliferation and signalling in BC3H-1 muscle cells. Evidence for specific binding sites 26
In vivo angiogenic effects of neutral heparin/peptide complexes 25
Rapid activation of de novo synthesis of diglycerides by temperature shift down in rat fibroblasts transformed by temperature sensitive mutants LA29 Rous sarcoma virus. 21
Totale 2.894
Categoria #
all - tutte 7.973
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.973


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020640 56 57 12 59 60 91 62 87 57 32 56 11
2020/2021421 42 18 42 35 5 69 9 41 35 58 30 37
2021/2022281 8 15 3 20 20 15 14 15 24 9 67 71
2022/2023712 81 60 38 64 78 149 85 53 66 6 20 12
2023/2024198 12 27 38 20 5 18 4 48 3 9 8 6
2024/202543 43 0 0 0 0 0 0 0 0 0 0 0
Totale 2.894